Our results show that Pax5 is preferentially expressed in DKD and C4-2BER as compared to adenocarcinoma counterpart C4-2 and C4-2B respectively (Fig. 4A, B, Fig. S4A, C). This evidence concerns the gene PAX5 and adenocarcinoma.